Does MEPOLIZUMAB Cause Type 2 diabetes mellitus? 746 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 746 reports of Type 2 diabetes mellitus have been filed in association with MEPOLIZUMAB (Nucala). This represents 1.7% of all adverse event reports for MEPOLIZUMAB.
746
Reports of Type 2 diabetes mellitus with MEPOLIZUMAB
1.7%
of all MEPOLIZUMAB reports
580
Deaths
541
Hospitalizations
How Dangerous Is Type 2 diabetes mellitus From MEPOLIZUMAB?
Of the 746 reports, 580 (77.7%) resulted in death, 541 (72.5%) required hospitalization, and 509 (68.2%) were considered life-threatening.
Is Type 2 diabetes mellitus Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 746 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Type 2 diabetes mellitus?
ATORVASTATIN (7,556)
ADALIMUMAB (3,516)
PREDNISONE (3,484)
METHOTREXATE (3,465)
RITUXIMAB (3,318)
TOCILIZUMAB (3,145)
ABATACEPT (3,074)
LEFLUNOMIDE (3,033)
ALENDRONATE (3,002)
DICLOFENAC (2,974)
Which MEPOLIZUMAB Alternatives Have Lower Type 2 diabetes mellitus Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE